Business
REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2021 Conference
ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that two oral presentations will be presented at the Angiogenesis,
About this update from Regenxbio Inc.
[{"type":"text","content":"ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that two oral presentations will be presented at the Angiogenesis, Exudation, and Degeneration 2021 conference taking place virtually from February 12 to 13, 2021.\nThe presentations will be as follows:\nPresentation Title: Subretinal Gene Therapy for Exudative AMDPresenter: Allen C. Ho, M.D., Director of Retina Research at Wills Eye Hospital and Mid Atlantic Retina Date/Time: Saturday, February 13, 2021, 9:15 a.m. ET\nPresentation Title: Suprachoroidal Gene Therapy for Exudative AMD and Diabetic RetinopathyPresenter: Peter A. Campochiaro, M.D., Director, Retinal Cell and Molecular Laboratory, Professor of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of MedicineDate/Time: Saturday, February 13, 2021, 9:45 a.m. ET\nAbout REGENXBIO Inc.\nREGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.\nTrademarks referenced herein are registered trademarks of REGENXBIO.\nContacts:Tricia TruehartInvestor Relations and Corporate [email protected] \nInvestors:Brendan Burns, 212-600-1902 [email protected] \nMedia:David Rosen, [email protected]\n\n \n\n\n\n View original content to download multimedia:http://www.prnewswire.com/news-releases/regenxbio-announces-presentations-at-the-angiogenesis-exudation-and-degeneration-2021-conference-301222819.html\nSOURCE REGENXBIO Inc.","length":3782,"tagName":"div"}]